Alternate-day fasting: the longest-studied intermittent fasting protocol

Alternate-day fasting (ADF) alternates "fast" days of ~500 kcal with "feast" days of unrestricted eating. It's the most-studied of the intermittent fasting patterns, largely thanks to two decades of work from Krista Varady's lab at the University of Illinois Chicago.

How ADF actually runs#

Strict ADF prescribes zero calories on fast days. Modified ADF (the version studied in most trials) allows ~25% of normal caloric intake on fast days (typically ~500 kcal). On feast days, no restrictions are imposed.

People who try strict ADF mostly drop it within a week. Modified ADF is the version that adheres in trials and is what most ADF research actually means.

What the trials show#

Weight loss. A 2017 JAMA Internal Medicine RCT (Trepanowski et al.) compared ADF to daily calorie restriction with matched weekly calories. Over 12 months, both produced ~6% body weight loss; the groups did not differ in weight outcomes or major cardiometabolic markers.

Adherence. In several trials, dropout from ADF arms was higher than from daily restriction arms, a real practical consideration. ADF works well for some people and not for others.

Cardiometabolic markers. Modest improvements in fasting insulin, HOMA-IR, triglycerides, and blood pressure are common. Effect sizes are similar to matched daily restriction.

Compensation on feast days. People do eat more on feast days than they would on a normal eating day, typically about 110–125% of normal intake. They do not, on average, fully compensate for the fast-day deficit. The net weekly deficit is what drives weight loss.

Where ADF differs from 5:2#

5:2 spreads the deficit across 2 days/week; ADF across roughly 3.5 days. The total weekly caloric deficit at matched protocols is larger with ADF if feast-day intake is held constant.

This makes ADF the more aggressive option. For people who tolerate it, weight loss is somewhat faster. For people who struggle, the higher frequency of restriction means more difficulty.

The 12-month adherence data favours 5:2 for most populations. Short-term trials (8–12 weeks) often favour ADF for raw weight outcomes.

Hormonal considerations#

ADF in lean active women is the group most likely to see menstrual changes: see fasting-and-womens-hormones. The combination of frequent low-calorie days and high training load can drive low energy availability.

In adults with overweight, hormonal disruption from ADF is uncommon.

Practical patterns#

Common ADF rhythms that adhere:

• Fast Sunday, Tuesday, Thursday; feast the other days
• One 1–2 meal day per alternate day
• High protein on fast days to preserve lean mass and increase satiety
• Caffeine and water freely on fast days

The hardest part for most people is the social calendar. Trial protocols don't require rigid adherence. Flexibility around dinner invitations and family meals is part of how people sustain it long-term.

Who should not do ADF#

• History of disordered eating
• BMI ≤18.5 or unintentional weight loss
• Pregnancy or breastfeeding
• Type 1 diabetes
• On insulin or sulfonylureas without clinical adjustment
• Athletic populations doing high training volumes (low energy availability risk)
• Children and adolescents

What we'd actually say#

ADF works for the people who can adhere to it. It's not magic: it produces weight loss because it produces a caloric deficit, and trial data show no metabolic advantage over matched daily restriction.

For most readers, 16:8 or 5:2 are easier entry points. If you've tried those and ADF appeals more behaviourally, the safety profile and evidence base support a trial in suitable adults.

When to talk to a clinician#

• Diabetes on any glucose-lowering medication
• History of disordered eating
• Pregnancy or breastfeeding
• Persistent dizziness, weakness, or lightheadedness on fast days
• Female athletes with cycle changes after starting ADF